Companion diagnostic tests for treatment of lung cancer patients: what are the current and future challenges?

Hofman, Paul; Barlesi, Fabrice

Hofman, Paul; Barlesi, Fabrice.

Affiliation

Hofman P; a Laboratory of Clinical and Experimental Pathology, FHU OncoAge, and Hospital-integrated Biobank , Côte d'Azur University , Nice , France.
Barlesi F; b CRCM, INSERM, CNRS, AP-HM, Multidisciplinary Oncology and Therapeutic Innovations Department , Aix Marseille University , Marseille , France.

Expert Rev Mol Diagn ; 19(5): 429-438, 2019 05.

Article in En | MEDLINE | ID: mdl-31018102

Subject(s)

Biomarkers, Tumor/genetics; Diagnostic Tests, Routine; Lung Neoplasms/diagnosis; Thoracic Neoplasms/diagnosis; B7-H1 Antigen/isolation & purification; B7-H1 Antigen/therapeutic use; Clinical Decision-Making; Humans; Immunohistochemistry/trends; Immunotherapy/trends; Lung Neoplasms/immunology; Lung Neoplasms/pathology; Lung Neoplasms/therapy; Thoracic Neoplasms/immunology; Thoracic Neoplasms/pathology; Thoracic Neoplasms/therapy

Key words

Companion diagnostic test; biomarker; limits; lung cancer; sensitivity; specificity

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Thoracic Neoplasms / Biomarkers, Tumor / Diagnostic Tests, Routine / Lung Neoplasms Type of study: Diagnostic_studies / Prognostic_studies Limits: Humans Language: En Journal: Expert Rev Mol Diagn Journal subject: BIOLOGIA MOLECULAR Year: 2019 Document type: Article Affiliation country: France

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google